Delivery Order SPE2DB22D3301-SPE2DB25FX5FG

Award Date 11/8/24
Potential Completion Date 11/12/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX5FG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,024.00 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. This particular delivery order is for the HAVRIX 720 Unit/0.5 mL syringe 0.5mL, a vaccine product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's federal contract awards demonstrate its extensive capabilities in distributing a wide array of critical medical commodities to various government agencies, particularly the DLA and the Department of Justice Federal Bureau of Investigation.

Generated 2/7/25, 9:10 AM